Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38K Buy
58
+51
+729% +$3.83K ﹤0.01% 695
2025
Q4
$521 Hold
7
﹤0.01% 719
2025
Q3
$472 Hold
7
﹤0.01% 747
2025
Q2
$456 Hold
7
﹤0.01% 754
2025
Q1
$432 Buy
+7
New +$464 ﹤0.01% 761

Other funds holding HOLX

Brown, Lisle/Cummings's HOLX Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Hologic (HOLX) stake by 729% in Q1 2026, buying an estimated $3.83K and bringing the position to 58 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Brown, Lisle/Cummings first reported a position in HOLX in Q1 2025 and has held it in 5 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Brown, Lisle/Cummings held 58 shares of Hologic worth $4.38K as of Q1 2026.
  • Brown, Lisle/Cummings bought 51 Hologic shares in Q1 2026, an estimated $3.83K.
  • Hologic made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #695 holding.
  • Brown, Lisle/Cummings first reported a position in Hologic in Q1 2025 and has held it in 5 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.